Browsing Tag
Invus
2 posts
Aclaris Therapeutics prices $50m share offering following positive ATI-052 trial results
Aclaris Therapeutics targets $50M financing after ATI-052 trial success. Explore its cash position, dilution risks and Phase 2b strategy.
Could one hair loss antibody make Absci’s AI drug platform harder to ignore?
Absci’s ABS-201 data and $100 million raise sharpen ABSI’s AI biologics story across androgenetic alopecia, endometriosis and platform validation.